Ex-Watson COO joins Cardinal
Executive Summary
Cardinal Health names former Watson COO Joseph Papa as CEO-pharmaceutical technologies and services business. Papa will be responsible for drug development, formulation, sterile manufacturing, packaging and marketing services. Papa chose not to remain at Watson as president-brand business under the company's reorganization (1"The Pink Sheet" Nov. 1, 2004, p. 22)...
You may also be interested in...
Watson Restructuring To Create Brand, Generic Units
Watson believes it may take up to six months to complete its search for two presidents to head up the company's new brand and generic business units
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.